Check out our most popular compounded medications! Get Started
Atovaquone 250 mg/5 ml/Proguanil HCl 100 mg/5 ml Oral Suspension is a compounded formulation used to treat a range of conditions including malaria, pneumocystis pneumonia, toxoplasmosis, babesiosis, and Chagas disease. This medication is a liquid dosage form, ensuring a uniform dispersion of ingredients for effective administration.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Atovaquone 250 mg/5 ml/Proguanil HCl 100 mg/5 ml Oral Suspension is a compounded formulation designed to treat malaria. This medication is a combination of two active ingredients, atovaquone and proguanil hydrochloride, which work synergistically to prevent and treat malaria. Atovaquone functions by inhibiting the growth of the malaria parasite, while proguanil hydrochloride blocks the action of an enzyme vital for the parasite's survival.
The medication is available in a suspension form, a liquid dosage form in which the active ingredients are uniformly dispersed throughout a liquid medium. This ensures a homogeneous mixture for administration, providing consistent dosing with each use. It is crucial to take this medication exactly as prescribed by your healthcare provider and to complete the entire course of treatment. Timely administration of all doses and avoiding missed doses is key to the effectiveness of this medication.
Atovaquone 250 mg/5 ml/Proguanil HCl 100 mg/5 ml Oral Suspension is generally well tolerated by most patients. However, some common side effects may include nausea, vomiting, diarrhea, and headache. If you experience any of these side effects, or any other unusual symptoms, it is important to contact your healthcare provider immediately.
At Bayview Pharmacy, we are experienced compounding pharmacists who can provide you with comprehensive information about Atovaquone 250 mg/5 ml/Proguanil HCl 100 mg/5 ml Oral Suspension and its role in malaria treatment. If you have any questions or concerns about this medication, please do not hesitate to reach out to us. We are here to assist you in your healthcare journey.
Atovaquone 250 mg/5 ml/Proguanil HCl 100 mg/5 ml Oral Suspension is a compounded formulation specifically designed for the treatment and prevention of acute, uncomplicated Plasmodium falciparum malaria. This formulation is suitable for use in both adults and pediatric patients who weigh at least 5 kg. However, it is not recommended for use in pregnant women or in patients with severe renal impairment due to potential health risks.
The medication is presented in a liquid dosage form, with the active ingredients uniformly dispersed throughout the liquid medium. This ensures a homogeneous mixture for administration, providing consistent dosing and efficacy. To minimize the risk of gastrointestinal side effects, patients are advised to take the medication with food or milk.
It is crucial for patients to complete the full course of treatment, even if they start to feel better after a few days. This is to ensure the complete eradication of the malaria parasite from the body, preventing relapse and resistance. Patients should be closely monitored for any signs and symptoms of adverse reactions, which may include rash, pruritus, and gastrointestinal symptoms. If any of these symptoms occur, patients should immediately contact their healthcare provider for advice and potential treatment adjustments.
As with all medications, it is important to use Atovaquone 250 mg/5 ml/Proguanil HCl 100 mg/5 ml Oral Suspension responsibly and under the guidance of a healthcare professional. If you have any questions or concerns about this formulation, please do not hesitate to contact your healthcare provider.
Atovaquone 250 mg/5 ml/Proguanil HCl 100 mg/5 ml Oral Suspension is a compounded formulation of two potent antimalarial medications, Atovaquone and Proguanil HCl. This combination medication is designed to treat and prevent malaria, a life-threatening disease caused by parasites that are transmitted to people through the bites of infected mosquitoes.
The medication works by inhibiting the growth of parasites in the red blood cells.
This oral suspension is typically administered once a day. It is crucial to take this medication exactly as prescribed by your healthcare provider, neither exceeding nor reducing the recommended dosage. To ensure optimal absorption, it is advised to take this medication with food or a full glass of water.
Atovaquone 250 mg/5 ml/Proguanil HCl 100 mg/5 ml Oral Suspension is used to prevent and treat malaria caused by specific types of parasites. Therefore, it is essential to complete the entire course of treatment as prescribed by your healthcare provider.
Like all medications, Atovaquone 250 mg/5 ml/Proguanil HCl 100 mg/5 ml Oral Suspension may cause side effects. These can include nausea, vomiting, diarrhea, headache, dizziness, and rash. If you experience any of these side effects, it is important to contact your healthcare provider immediately.
If you have any questions or concerns about Atovaquone 250 mg/5 ml/Proguanil HCl 100 mg/5 ml Oral Suspension, do not hesitate to reach out to your healthcare provider or pharmacist. They are equipped with the knowledge and expertise to provide you with the necessary information and guidance.
Atovaquone 250 mg/5 ml/Proguanil HCl 100 mg/5 ml Oral Suspension is a compounded formulation designed to treat a variety of protozoal infections, including cryptosporidiosis, isosporiasis, and cyclosporiasis. This formulation is also commonly used as a preventative measure against malaria for travelers visiting areas where the disease is prevalent. The medication is dispersed uniformly throughout a liquid medium, ensuring a homogeneous mixture for administration.
It is crucial to note that this formulation is not recommended for children under the age of 8 years. Adherence to the prescribed dosage by your healthcare provider is of utmost importance. It is advised to complete the entire course of this medication, even if symptoms improve before the completion of the course. In case a dose is missed, it should be taken as soon as possible, and the regular schedule should be continued. Doubling up on doses to compensate for a missed one is not recommended.
If there are any queries or concerns regarding the use of Atovaquone 250 mg/5 ml/Proguanil HCl 100 mg/5 ml Oral Suspension, it is recommended to seek professional advice. It is always important to use this medication responsibly and under the guidance of a healthcare provider.
Atovaquone/Proguanil HCl Oral Suspension is a liquid medication that contains Atovaquone and Proguanil Hydrochloride. These active ingredients are uniformly dispersed throughout a liquid medium to provide a homogeneous mixture for administration.
The strength of this medication is Atovaquone 250 mg/5 ml and Proguanil HCl 100 mg/5 ml.
This medication should be stored at room temperature, away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.
This medication should be taken orally as directed by your healthcare provider. The dosage is based on your medical condition, weight, and response to treatment.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Take your next dose at the regular time. Do not double the dose to catch up.
Side effects may include stomach upset, nausea, vomiting, stomach pain, diarrhea, or headache. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.
Before using this medication, tell your doctor or pharmacist if you are pregnant or planning to become pregnant. This medication should be used only when clearly needed during pregnancy. Discuss the risks and benefits with your doctor. It is unknown if this medication passes into breast milk. Consult your doctor before breastfeeding.
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription/herbal products you may use, especially of other medications for malaria. Keep a list of all your medications with you, and share the list with your doctor and pharmacist.
In case of overdose, get medical help or contact a Poison Control Center immediately. Symptoms of overdose may include severe nausea, vomiting, or diarrhea.
If you have an allergic reaction, such as rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, or trouble breathing, get medical help right away.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
